Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Aspire Biopharma Holdings, Inc. (ASBP) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.00M |
|
$-1.85M |
|
$0.00M |
|
$0.00M |
|
$1.15M |
|
$-1.15M |
|
$-0.70M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.85M |
|
$-1.15M |
|
$-1.15M |
|
49.53M |
|
49.53M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$2.40M |
|
-- |
|
-- |
|
$2.40M |
|
$13.86M |
|
-- |
|
$0.01M |
|
$13.87M |
|
$-11.47M |
|
$-11.47M |
|
$-11.47M |
|
49.53M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
-- |
|
$5.94M |
|
$0.00M |
|
$1.95M |
|
$1.94M |
|
$14.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-0.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
-- |
|
-- |
|
16.14% |
|
16.14% |
|
-77.00% |
|
16.14% |
|
$-0.23 |
|
$-0.08 |
|
$-0.08 |
|